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PNS axons have a high intrinsic regenerative ability, whereasmost CNS axons show little regenerative response.We show that activation
of Neu3 sialidase, also known as Neuraminidase-3, causing conversion of GD1a and GT1b to GM1 ganglioside, is an essential step in
regeneration occurring in PNS (sensory) but not CNS (retinal) axons in adult rat. In PNS axons, axotomy activates Neu3 sialidase,
increasing the ratio of GM1/GD1a and GM1/GT1b gangliosides immediately after injury in vitro and in vivo. No change in the GM1/GD1a
ratio after axotomywasobserved in retinal axons (in vitro and in vivo), despite thepresenceofNeu3 sialidase. Externally applied sialidase
converted GD1a ganglioside to GM1 and rescued axon regeneration in CNS axons and in PNS axons after Neu3 sialidase blockade. Neu3
sialidase activation in DRGs is initiated by an influx of extracellular calcium, activating P38MAPK and then Neu3 sialidase. Ganglioside
conversion by Neu3 sialidase further activates the ERK pathway. In CNS axons, P38MAPK and Neu3 sialidase were not activated by
axotomy.
Key words: axon regeneration; axotomy; gangliosides; Neu3 sialidase
Introduction
Mammalian CNS axons fail to regenerate after damage, whereas
PNS axons can regenerate vigorously, many reconnecting with
their targets. Mature CNS axons have been shown to be intrinsi-
cally poor at regenerating even in permissive environments (Sun
and He, 2010; Moore and Goldberg, 2011; Wang and Jin, 2011;
Chew et al., 2012; Cho and Cavalli, 2012). Successful axon regen-
eration begins with growth cone formation involving coordi-
nated proteolytic, cytoskeletal, and cell surface regulatory events
(Bradke and Dotti, 1999; Long and Lemmon, 2000; Erez et al.,
2007;Witte et al., 2008; Afshari et al., 2009; Bradke et al., 2012) as
well as activation of local protein translation as in PNS axons
(Zheng et al., 2001; Verma et al., 2005). Integrins and other sig-
naling molecules involved with control of regeneration can asso-
ciate with lipid microdomains, leading to modulation of many
intracellular signaling events (Guirland et al., 2004; Kamiguchi,
2006; Guirland and Zheng, 2007; Grider et al., 2009; Ohkawa et
al., 2010; Stuermer, 2010; Gao et al., 2011; Norambuena and
Schwartz, 2011).
Gangliosides, complex glycosphingolipids on the plasma
membrane containing one or more sialic acid residues, are key
components of microdomains. The adult mammalian nervous
system has four dominant types of gangliosides: GM1, GD1a,
GD1b, and GT1b. Whereas embryos can develop normally
without complex gangliosides, postnatally they develop demy-
elination, neurodegeneration, and impaired peripheral nerve
regeneration (Sheikh et al., 1999; Okada et al., 2002; Kittaka et
al., 2008). GM1 ganglioside has been shown to promote axon
growth (Facci et al., 1984; Skaper et al., 1985) and regeneration
(Yang et al., 2006; Mountney et al., 2010), but a clinical trial of
GM1 treatment in spinal cord injury was not successful (Gei-
sler et al., 2001). GD1a ganglioside, on the other hand, has
been shown to be a receptor for inhibition of axon growth by
MAG (Vyas et al., 2002; Zhang et al., 2011), and GT1b forms a
complex with the Nogo receptor to inhibit axon growth (Wil-
liams et al., 2008). Neu3 sialidase, an enzyme that hydrolyzes
polysialic acid-containing gangliosides to GM1 ganglioside
(Geisler et al., 2001; Vyas et al., 2002), acts on outer sialic acid
groups and has been shown to effectively increase GM1 levels
(Oehler et al., 2002; Monti and Miyagi, 2012). Additionally,
Neu3 has been shown to be necessary for neuronal differenti-
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ation (Da Silva et al., 2005), for maintenance of polarity after
axotomy (Rodriguez et al., 2001), and for regulating invasive
and migratory activity (Yamaguchi et al., 2006; Miyata et al.,
2011; Tringali et al., 2012).
In this paper, we examine Neu3 sialidase action on axonal
gangliosides and resultant axon regeneration, and we assess
whether these mechanisms help to explain the different regener-
ation capacities of CNS and PNS axons. We find that after PNS
axotomy, but not CNS, Neu3 sialidase converts GD1a to GM1.
Pharmacological blocking of Neu3 sialidase, downregulation of
Neu3 with siRNA, or depleting gangliosides all inhibit PNS re-
generation. Conversely, exogenously applied sialidase increases
GM1 ganglioside and promotes regeneration in CNS axons, sug-
gesting that conversion of polysialyated gangliosides is necessary
for axon regeneration.
Materials andMethods
Chemicals and reagents
All chemicals, antibodies, and reagents were purchased from Sigma-
Aldrich, unless otherwise specified.
DRG cultures
Adult (3- to 4-month-old) male Sprague Dawley rats were euthanized
and DRGs removed.
Explants
DRGs were trimmed of meningeal coverings, divided into segments, and
plated onto coated chamber slides (Nunc) [10 g/ml poly-D-lysine
(PDL) and 1 g/ml laminin]. Explants were maintained at 37°C and 7%
CO2 in DMEM (Invitrogen) with 0.11 g/L sodium pyruvate with pyro-
dixine, 4.5 g/L glucose, 20 ng/ml NGF, 1% insulin-transferrin-selenium,
1% penicillin-streptomycin-fungizone.
Dissociated DRGs
DRGs were dissociated with 0.2% collagenase followed by 0.1% trypsin
and triturated with Pasteur pipettes of decreasing tip diameters. The
suspension was centrifuged through a density gradient (15% BSA). Cells
were cultured in DMEM supplemented with 10% FBS (Invitrogen), 1%
penicillin-streptomycin-fungizone, 0.1% mitomycin-C, and 10 ng/ml
NGF and plated on PDL (20 g/ml) laminin (10 g/ml).
Retina explant cultures
Unilateral conditioning optic nerve crush was performed on adult male
SpragueDawley rats, 7 d before retinal dissection. Retinas were separated
from underlying pigment epithelium and sclera in HBSS before mount-
ing flat onto Petri dishes and cutting into 400-m-thick sections using a
McIlwain tissue chopper (Vibratome). Retinal sections were plated onto
plastic chamber slides coatedwith 300g/ml PDL and 10g/ml laminin,
with the ganglion cell layer facing the substratum. Cultures were main-
tained in DMEM and Neurobasal-A (Invitrogen) in a 1:1 ratio, supple-
mented with 50 IU erythropoietin-A, 760 g/ml BSA, N2 supplement
(Invitrogen ), 100 g/ml sodium pyruvate, 4 g/ml of T3-T4, 2 mM
glutamine (Invitrogen), 1.1 mg/ml glucose, 100 g/ml gentamycin (In-
vitrogen), and 50 ng/ml ciliary neurotrophic factor.
Axon regeneration assay
Axons were grown for 48–72 h (DRGs) or 5–7 d (retina explants) and
then axotomized with a pulled glass electrode leaving the site of axotomy
clearly demarcated on the plastic chamber slide. Axons were photo-
graphed immediately, 15 min, and 1 h after injury and assessed for re-
generation. Images were captured on a Nikon phase-contrast ELWD 0.3
microscope equipped with a Nikon DXM 1200 digital camera using a
10 (10/0.25) or 20 (20/0.4) objective lens. For analysis, only cut
axons that had retracted and begun to grow back were regarded as regen-
erating axons.
Pharmacological treatments
Inhibition of ganglioside synthesis. Axons were treated with either
fumonisin B1 (3 M) or ()-threo-1-phenyl-2-decanoylamino-3-
morpholino-1-propanol hydrochloride (PDMP) (20 M) 18 h before
axotomy.
Modulation of Neu3 sialidase activity. Axons were treated with
2,3,dehydro-2,deoxy-N-acetylneuraminic acid (NeuAc2en; 800 M) for
inhibition of Neu3 sialidase activity and/or with exogenous Clostridium
sialidase (0.4 IU; Roche), immediately before axotomy. NeuAc2en was
removed before adding Clostridium sialidase as NeuAc2en inhibited
Clostridium sialidase activity.
Modulation of signaling pathways. To analyze the regulation of Neu3
sialidase activity after adult DRG axotomy, one of the following was
added to the media 30 min before axotomy and left in the media for a
further 60min: U0126 (MEK-ERK inhibitor, 20M, Promega), rapamy-
cin (mTOR inhibitor, 10 nM, Calbiochem), and SB203580 (P38MAPK
inhibitor, 5 M, Calbiochem). Anisomycin (10 M, Alomone Labs) was
used to activate P38MAPK.
To examine the effect of absence of eCa2 on Neu3 sialidase activity
and axonal regeneration, cultures were incubated with normal growth
media devoid of CaCl2, 30 min before axotomy.
siRNA transfection
Dissociated DRGs were transfected with siRNA 48 h after plating. The
Neu3 siRNA consists of four siRNA sequences: GCAGAGAUGCGUAC-
CUCAA, CCAACAACUCUGCGAGCCU, CCAAACAAAUUCCGAG-
CAG, and GGACAGGGCUUGUUCGCGU (ON-TARGETplus SMART
pool rat Neu3 siRNA, 117185, Thermo Scientific). siGLO RISC-Free
siRNA (Thermo Scientific) was used as a negative control and transfec-
tion indicator. Briefly, DharmaFECT 3 (Thermo Scientific) and siRNA
were diluted separately in serum-free DMEM supplemented with 1%
insulin-transferrin-selenium and 10 ng/ml NGF before mixing together
and incubating with the DRGs (100 nM; 4 h) and then replacing with
normal medium.
RNA purification and RT-PCR
Dissociated DRGs were lysed and collected as per the manufacturer’s
instructions (PureLink RNAMini Kit, Invitrogen) before being homog-
enized (Ultra-Turrax T8 homogenizer, IKA-Werke). RNA purification
was performed before reverse transcription. The purified RNA was then
reverse-transcribed using the SuperScript III First-Strand Synthesis Su-
perMix (Invitrogen). The cDNA synthesis reaction was followed by PCR
with the following primers: Neu3, forward, 5-CAGCTGGGATAGCA-
GAGGTC-3; reverse, 5-GAGTCCTGAAGCAAGCCAAC-3, resulting
in a 209 bp fragment; Neu4, forward, 5-CCTGACCCTAGGACGAA-
CAG-3; reverse, 5-GATGTGCGTGGTGATCAGAG-3, resulting in a
179 bp fragment. The PCRwas run at 26, 29, and 32 cycles separately and
imaged using agarose gel electrophoresis.
Immunocytochemical staining of cultures
BothDRGand retina explant cultures were fixedwith 4%PFA for 10min
and washed with PBS before immunostaining. To analyze Neu3 sialidase
activity, we calculated the relative levels of GD1a (substrate) and GM1
(product) on individual axonal membranes rather than absolute mean
values of GD1a andGM1 ganglioside. Amean of 30–60 axons per cham-
ber (2 DRGs/chamber) was considered as n 1/experimental condition.
Fixed cultures were incubated with one of the following antibodies: rab-
bit anti-Neu3 sialidase/PMGS (Rodriguez et al., 2001),mouse anti-GD1a
ganglioside (kind gift from Prof. Ronald Schnaar, Johns Hopkins Uni-
versity, Baltimore, MD), mouse anti-GD1a ganglioside and mouse anti-
GT1b ganglioside (Merck Millipore) or stained using recombinant
cholera toxin-B subunit (CTB) conjugated to AlexaFluor-555 (Invitro-
gen), and mouse anti 3-tubulin. To analyze the signaling cascade regu-
lating Neu3 sialidase activity, DRG and retinal cultures were analyzed
with the following primary antibodies: mouse anti-P38MAPK, rabbit
anti-phospho P38MAPK, and rabbit anti-ERK andmouse anti-phospho
ERK (Cell Signaling Technology). Subsequently, cultures were washed in
PBS and incubated with the following fluorescent secondary antibodies:
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anti-rabbit AlexaFluor-660, and anti-mouse or anti-rabbit AlexaFluor-
488 (Invitrogen) before being mounted onto slides using Fluorosave
(Calbiochem).
Surgeries
All surgeries were performed in accordance with the United Kingdom
Animals (Scientific Procedures) Act of 1986 andUnited KingdomHome
Office regulations. Adult (2- to 3-month-old) male Sprague Dawley rats
were used for all in vivo experiments. Animalswere kept in 12 h light/dark
exposure, and food and water was provided ad libitum.
Animals were anesthetized using 1–2% isoflurane in a mixture of 50%
nitrous oxide and 50% oxygen for sciatic nerve surgery. The right sciatic
nerve was exposed and crushed proximal to its division into tibial and
common peroneal nerves with Dumont #5 forceps, crushing twice for
10 s duration each.
Optic nerve crushes were performed under ketamine:xylazine (2:1)
anesthesia at a dosage of 0.1 ml/100 g. The conjunctiva of the right optic
nerve was cut laterally near the cornea, and the retractor bulbar muscle
was separated. The optic nerve was exposed and cleared of fascial cover-
ings and crushed twice for 10 s duration each time.
Immunohistochemistry
Animals were euthanized with an overdose of Euthatal (sodium pento-
barbitol) at different time points after injury (2, 6, and 12 h) and tran-
scardially perfused with PBS, pH 7.4, and 4% PFA, pH 7.4. A 2-cm-long
segment of sciatic or optic nerve centered around the crush site (or
contralateral control nerves) was removed and postfixed overnight in 4%
PFA before cryoprotecting in 30% sucrose in PBS, pH 7.4. Tissue was
embedded in OCT (RA Lamb) and sectioned longitudinally at 12 m
(sciatic nerve) or at 10 m (optic nerve) thickness in a cryostat and
mounted on slides (Superfrost Plus; VWR).
Sections were permeabilized in 0.2% saponin in PBS and blocked
with 10% NGS and 2% BSA in PBS before incubating with one of the
following antibodies: rabbit anti neurofilament-heavy chain (sciatic
nerve) or rabbit anti-III tubulin, mouse anti-GD1a, CTB (for GM1
ganglioside), and anti-S100. Sections were rinsed in PBS-Saponin
before incubating with appropriate secondary antibodies, and cover-
slipping with Fluorosave.
Quantification of immunofluorescence
In vitro. Photographs of cut axons were captured on a Leica DM6000B
epifluorescent microscope equipped with a Leica DFC 350FX digital
camera (Leica) using a 40 objective lens (40/1.00–0.50 Oil). Image
acquisition using Leica Application Suite used identical exposure times
and microscope settings. Quantification of images was performed using
NIH ImageJ software.
In vivo. Photographs of sciatic (SN) and optic nerve (ON) sections
adjacent to the crush site were captured using a Leica TCS SP2 confocal
microscope (Leica) using 40 (40/1.15 Oil CS) (for SN) or 63 (63/
1.30 Oil CS) (for ON) magnification. Image acquisition using Leica Ap-
plication Suite used identical exposure times and microscope settings.
Image quantification was performed using confocal software using opti-
cal sections (0.800 m thick) to analyze the levels of GM1 and GD1a
gangliosides parallel and between axonal and Schwann cell markers. Ar-
eas of interest were randomly chosen based on areas adjacent and parallel
to NF-H-positive staining from a single confocal image. Intensities were
measured as ratio of CTB (for GM1 ganglioside):GD1a ganglioside nor-
malized against background. In experiments where CTB or Neu3 siali-
dase intensity was measured, normalization was performed using
intensity of an axonal marker, III-tubulin. To ensure that intensity
differences were not due to differences in axon size, intensity measure-
ments were normalized for the area of individual axon. Images were
processed with Adobe Photoshop CS4 and assembled in Adobe Illustra-
tor CS4.
Statistical analysis
Data were first analyzed for normality using Shapiro-Wilk normality test
(Origin version 8; Originlab). p values of all data were above set  levels
of 0.05 and therefore considered to be normally distributed. Results from
the analyses were expressed as mean  SEM. Statistical analysis was
performed using Prism version 5 (Graphpad). For all experiments, Stu-
dent’s t test (two-tailed), one-way ANOVA, and two-way ANOVA were
applied as appropriate. Significant interactions were analyzed using
paired t tests and Bonferroni post hoc tests as appropriate.
Results
Axotomy leads to an increase in the ratio of GM1/GD1a
gangliosides due to Neu3 sialidase activation
As a model of the first steps in successful axon regeneration, we
used regeneration of growth cones in adult DRG axons grown on
PDL/laminin. These axons regenerate a new growth cone and
begin to elongate within 30 min after axotomy (Chierzi et al.,
2005). We investigated levels of GM1 and GD1a gangliosides on
these axons and asked whether their relative levels change after
axotomy and during successful neurite regeneration. Both DRG
explant and dissociated cultures were fixed at 15 min or 1 h after
axotomy and stained with CTB (marker for GM1 ganglioside,
whichwe use throughout the paper to label GM1) and anti-GD1a
ganglioside antibody (Fig. 1). Axotomy led to conversion ofmost
of the GD1a to GM1, the ratio of GM1/GD1a having doubled
within 15 min and returned back to uncut levels by 1 h (Fig.
1A–C,G,H–J,N). The change in the ratio was observed along the
entire length of axons in our field of observation (200–300 m
from the proximal end of cut axons). Results are expressed as a
ratio between GM1 and GD1a because absolute levels in individ-
ual axons vary depending on axon size while the ratio varies little,
serving as a more representative indicator of local Neu3 sialidase
activity on axons. The overall ganglioside level, measured as
GD1aGM1, did not change significantly after axotomy or after
other our interventions, except for inhibition of ganglioside syn-
thesis (data not shown). Because desialylation of GD1a to pro-
duce GM1 on the cell surface is usually mediated by Neu3
sialidase, we confirmed the presence of Neu3 sialidase on DRG
axons by immunostaining using an antibody described previ-
ously (Rodriguez et al., 2001) (Fig. 1V). Axons were immunola-
beled without permeabilization demonstrating the presence of
Neu3 sialidase on the axonal surface, which could be removed by
inhibition of cholesterol synthesis with lovastatin or usingmethyl
 cyclodextrin (data not shown), additionally confirming its
presence in cholesterol-rich domains (Kopitz et al., 1996; Kalka et
al., 2001; Miyagi et al., 2008a,b). To verify that conversion of
GD1a to GM1 is due to the action Neu3 sialidase, we blocked its
activity inDRG explant cultures using the specific sialidase inhib-
itor, NeuAc2en (Rodriguez et al., 2001), or in dissociated DRG
cultures with siRNA for NEU3, the gene that generates Neu3
sialidase. The increase in GM1 after axotomywas greatly reduced
by NeuAc2en treatment; there was only a small change in the
GM1/GD1a ratio after axotomy (Fig. 1D–G). Using RNA inter-
ference for NEU3, we further confirmed that a reduction inNeu3
sialidase prevented the change in the GM1/GD1a ratio after axo-
tomy (Fig. 1K–N; controls described below). Furthermore, as
Neu3 sialidase acts to convert many gangliosides, including
GD1a, GT1b, GD1b, andGQ1b toGM1, we investigated whether
GT1b was also affected by axotomy. Comparable to GD1a, axo-
tomy led to conversion of GT1b to GM1, the ratio of GM1/GT1b
having almost tripled within 15 min and decreasing back near
uncut levels by 1 h (Fig. 1O–Q,U). After siRNA knockdown of
Neu3, the GM1/GT1b ratio was unchanged after axotomy (Fig.
1R–U). To determine whether axotomy increases GM1 conver-
sion through Neu3 sialidase upregulation or by activation, we
compared Neu3 sialidase protein levels on uncut axons and on
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Figure1. DRGaxotomy causes a transient increase in the ratio of GM1/GD1a andGM1/GT1bgangliosides. I, Schematic of experimental design. II, Fluorescent images of adult DRGexplants (A–F )
or dissociated DRGs (H–M,O–T ) with axons uncut (A,D,H, K,O, R), 15min (B, E, I, L,O, P, S), or 1 h after axotomy (C, F, J,M,Q, T ). DRGs are double-labeled for GD1a ganglioside (green) in A–F,
H–M (or GT1b ganglioside inO–T ) and CTB for GM1 ganglioside (red) under normal conditions (A–C,H–J,O–Q), after exposure to NeuAc2en (D–F ), or after Neu3 siRNA transfection (K–M,R–T ).
In this and subsequent images, axotomy/nerve crush is indicated by dashed yellow lines, where applicable. GM1 and GD1a or GT1b ganglioside intensitieswere plotted ( SEM) inG (DRG explants,
40–50 axons/chamber, 2 DRG/chamber,n 4 chambers) orN,U (dissociatedDRGs, 2 axons/chamber,n 5). III, Reduction of Neu3 expressionwithNeu3 siRNA.V,W, Fluorescent images of adult
DRG neurons after immunocytochemistry for Neu3 sialidase, without siRNA transfection (V ), or after Neu3-siGLO transfection (W ). Neurons transfected with Neu3-siGLO (red; W ) have reduced
intensity forNeu3 sialidase staining (green).X, RT-PCRof siRNA-transfected adult DRGneurons, run at 26, 29, and32 cycles. Neu3 siRNA is specific in knockingdown the expressionofNeu3by70%
and has no effect on Neu4, a closely related sialidase. Controls are siGLO-transfected-only neurons (nonfunctional and nontargeting siRNA). *p 0.05 (one-way or two-way ANOVA, where
appropriate). **p 0.01 (one-way or two-way ANOVA, where appropriate). ***p 0.001 (one-way or two-way ANOVA, where appropriate). Scale bars: A for A–F, 25m;H forH–M andO–T,
50m; V–W, 250m.
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Figure 2. Reduction of Neu3 sialidase activity by the inhibitor, NeuAc2en, or by Neu3 siRNA transfection reduced regeneration after axotomy but not axon growth rate. I, Phase-
contrast photomicrographs showing axons of DRG explants (A–D) or dissociated DRGs (F–K ) immediately (A, C, F, I ), 15 min (dissociated DRGs only; G,J ), or 1 h after axotomy (B, D, H,
K ), under control conditions (A, B, F–H ), and after exposure to NeuAc2en (C, D), or Neu3 siRNA transfection (I–K ). Percentage regeneration 1 h after axotomy ( SEM) plotted in E (n
6 DRG explants) or after Neu3 siRNA transfection in L (2 axons/chamber, n 15 chambers, dissociated DRGs). Arrows/arrowheads indicate axons that were cut, retracted at 15 min, and
regenerated at 1 h. C, D, An uncut axon that continued to grow in the presence of NeuAc2en. K, Inset, A merged phase-contrast and fluorescent image of the DRG cell body from I–K
demonstrating the presence of siGLO (red) confirming the siRNA uptake in the neuron. Controls (F–H ) were performed with siGLO transfection only, or no treatment (A, B). II, M–O,
Phase-contrast photo-montages of adult DRG axons 18 h after exposure to PDMP (M ), 1 h after exposure to NeuAc2en (N ), and control (O). Photo-montages from similar areas were taken
before addition of drugs and analyzed for growth rate in these as well as in corresponding control axons. Axon lengths were measured in drug-treated cultures and compared with
corresponding control cultures to calculate the growth rate of axons (in m/h;  SEM), which is plotted in P (each column represents a mean of 30 – 40 axons from n  3
chambers/condition). ***p 0.001 (two-tailed Student’s t test). Scale bars: A–D, 20m; F–K, 100m; K, inset, 50m; M–O, 200m.
Kappagantula et al. • Neu3 Sialidase Is Required for Axon Regeneration J. Neurosci., February 12, 2014 • 34(7):2477–2492 • 2481
axons 15 min after injury by immunocytochemistry (Rodriguez
et al., 2001; Da Silva et al., 2005). No significant change in Neu3
sialidase staining intensity was observed at 15 min after injury
(data not shown), suggesting that an increase in Neu3 sialidase
activity rather than an increase in expression or targeting to
membrane was responsible for the acute rise in GM1/GD1a ratio
after axotomy. These results indicate that reduction inNeu3 siali-
dase activity will reduce the level of desialytion of many ganglio-
sides to GM1. However, to streamline our analyses for remaining
experiments, we have chosen to assess changes in the ratio of
GM1/GD1a intensity.
Knocking down the expression of Neu3 sialidase with siRNA
does not affect the levels of closely related sialidases
To verify that the observed effect of knockdown of Neu3 onGM1
and GD1a and GT1b was specifically due to Neu3 sialidase, we
evaluated expression levels of other related sialidases. After treat-
mentwithNEU3 siRNA,RT-PCRdemonstrated a distinct reduc-
tion in Neu3 levels in dissociated DRG cultures, whereas levels of
Neu4 remained unaffected (Fig. 1X). Immunohistochemical
staining for Neu3 sialidase in NEU3 siRNA-transfected cultures
revealed decreases in Neu3 sialidase levels, indicating a reduction
in Neu3 sialidase protein level compared with control cultures
(Fig. 1V,W). As the NEU3 siRNA specifically reduced only Neu3,
leaving Neu4 constant, our results suggest that changes in Neu3
sialidase activity are responsible for the conversion of GD1a (and
GT1b) to GM1.
Inhibiting Neu3 sialidase activity reduces axon regeneration
after axotomy
Because Neu3 sialidase activation converts more complex gan-
gliosides to GM1 ganglioside and because GM1 has been shown
to promote axonogenesis and axon growth, we hypothesized that
inhibiting Neu3 sialidase’s activity might inhibit regeneration in
adult DRG axons. DRG explants (or dissociated DRG cultures)
were grown for 48 h on PDL-laminin, exposed to NeuAc2en for
1 h (or siRNA transfection for 4 h followed by a 1 d incubation),
axotomized, and regeneration was assessed at 15 min and 1 h.
Figure 3. Neu3 sialidase is transiently activated in the sciatic nerve after crush injury.A,A, Confocalmicrograph of sciatic nerve immunolabeledwith S100 (green), CTB (red), andIII-tubulin
(blue). Area within dotted line (A) indicates representative regions parallel to axonal staining (blue) used to measure the intensities of GM1 and GD1a gangliosides. Schwann cell staining (green)
performed to show its relative position to area of measurement. B–D, Fluorescent confocal images (longitudinal) of sciatic nerve uncrushed (B, B), 6 h after crush (6 h; C, C), and 12 h after crush
(12 h; D, D), triple-labeled for neurofilament-heavy chain (green), GD1a (blue), and GM1 gangliosides (CTB, red), with high-magnification images from dotted squares shown on right. Arrows
indicate representative regions adjacent and parallel to axonal staining (NF-H-positive) used for measuring GM1 and GD1a ganglioside intensities. E, The ratio of GM1/GD1a ganglioside intensities
( SEM) over time after injury is plotted (n 6/time point). ***p 0.001 (one-way ANOVA). Scale bars: A–D, 50m; A–D, 25m. Orientation of figures: top, caudal; bottom, rostral.
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Compared with untreated cultures (Fig. 2A,B,F–H), NeuAc2en-
treated DRG explants (Fig. 2C,D) and Neu3 siRNA-transfected
dissociated DRGs (Fig. 2I–K) showed a marked reduction in re-
generation (Fig. 2E,L). Axons were scored as regenerating if a
growth cone was present at their tip and they had grown beyond
their retraction point (Fig. 2B,G). Within dissociated cultures,
retraction of axons in controls was most obvious within 15 min
after axotomy, with regeneration occurring between 15 min and
1 h. Uncut axons within the same cultures continued to grow in
the presence of NeuAc2enwith normal growth conemorphology
(Fig. 2C,D). Additionally, we attenuated total ganglioside synthe-
sis using two different inhibitors, fumonisinB1 and PDMP, and
found that adult DRG axon regeneration was severely impaired
(data not shown). To rule out toxicity from the ganglioside in-
hibitors, we measured the growth rate of uncut axons in the
presence of PDMP or NeuAc2en and found no difference be-
tween treated and control cultures over the same periods (Fig.
2M–P) with axon growth in uncut DRG cultures not affected by
NeuAc2en (Fig. 2N). These results suggest that theGD1a toGM1
conversion mediated by rapid activation of Neu3 sialidase
during the retraction period plays a significant role in the
regeneration of cut DRG axons. However, high levels of GM1, or
likewise reduced levels of complex gangliosides such as GD1a, are
not needed for the continuing growth of mature axons.
Sciatic nerve crush leads to GD1a to GM1 conversion in vivo
We next investigated whether the conversion of GD1a to GM1
after axotomy occurs in the PNS in vivo. Sciatic nerve crushes
were performed in adult rats, and the GM1/GD1a ganglioside
ratio was measured immunohistochemically. To visualize changes
in the vicinity of axon surfaces, we measured the intensity of GD1a
andGM1 in single optical sections, selecting narrow areas of interest
Figure 4. Exogenous sialidase rescues NeuAc2en-mediated inhibition of Neu3 sialidase activity and promotes axonal regeneration. I, Schematic of experimental design for sialidase rescue
experiments in adult DRG axons. II, A–F, Fluorescent photomicrographs after exposure to Neu3 sialidase inhibitor (NeuAc2en) for 1 h, whichwas removed and followed by no treatment (NeuAc2en
control;A–C) or exposure to exogenous Clostridium sialidase (NeuAc2en Sialidase;D–F ) with axotomy performed 30min later showing adult DRG axons uncut (A,D), 15min (B, E), and 1 h after
axotomy (C,F ), double-labeled for GD1a (green) and GM1gangliosides (CTB, red). The ratio of GM1/GD1a gangliosides ( SEM)was plotted inG, with the GM1 and GD1a ganglioside intensity ratio
normalized to background (n 4). ***p 0.001 (two-way ANOVA). H–K, Phase-contrast photomicrographs showing DRG axons immediately after axotomy (H, J ) and 1 h after exposure to
NeuAc2en and removal (NeuAc2en control; H, I ), or after exposure to NeuAc2en followed by exogenous Clostridium sialidase (NeuAc2en Sialidase; J, K ). Arrows indicate selected axons at
axotomy and after 1 h. Percentage regeneration ( SEM) 1 h after axotomy plotted in L (n 6). ***p 0.001 (Student’s two-tailed t test). Scale bars: A–F, 50m; and H–K, 30m.
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Figure 5. Neu3 sialidase remains inactivated after retinal axonal injury; however, exogenous sialidase can promote retinal axon regeneration. I, Schematic of timeline for retinal axon experi-
ments. II, A–D, Fluorescent photomicrographs of adult retinal axons 15 min after axotomy. Axons are double-labeled for GD1a (A, C) and GM1 gangliosides (CTB; B, D) under normal conditions
(control 15 min; A, B) or after exposure to Clostridium sialidase (sialidase 15 min; C, D). E, Fluorescent photomicrograph showing Neu3 sialidase enzyme on an adult retinal axon. The ratio of
GM1/GD1a ganglioside is plotted in F (30–40 axons/chamber, n 6).G–I, Fluorescent confocal photomicrographs (longitudinal) of optic nerve uncrushed (G,G), 6 h (H,H), and 12 h after crush
(I, I), triple-labeled for III-tubulin (green), GD1a (blue), and GM1 gangliosides (CTB, red). High-magnification images () from the dotted squares in the corresponding pictures denote
representative areas used for GD1a and GM1 quantification. Arrows indicate regions parallel to axonal staining used formeasuring intensities of GM1 and GD1a gangliosides. The ratio of GM1/GD1a
gangliosides ( SEM) parallel to axonal staining before and after optic nerve injury and normalized against background intensity levels is plotted in J (n 3). p values by one-way ANOVA. K–N,
Phase-contrast photomicrographs showing retinal axons at time of axotomy (0min;K,M ) and 1 h after axotomy (1 h; L,N ), retracting under normal conditions (control;K, L), or regenerating after
exposure to Clostridium sialidase applied 30min before axotomy (sialidase;M,N ). Plots ofmeandistance of axon tip retraction from site of injurymeasured 1 h after injury in the presence or absence
of exogenous sialidase (n 6) (O) and percentage of axons that regenerated past retraction position in retinal axons 1 h after injury (n 6) (P) SEM. ***p 0.001; *p 0.05 (Student’s t test,
two-tailed). Scale bars: A–D, 100m; E, G–I, 25m; G–I, K–N, 50m.
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parallel to axons in between S100-stained Schwann cells and III-
tubulin or neurofilament stained axonal profiles (Fig. 3A). Normal
adult sciatic nerve had a very low ratio of GM1/GD1a (Fig. 3B,B).
However, this ratio changed after nerve crush resulting in a fourfold
increase within 6 h after crush injury, returning back to uncrushed
levels by 12 h (Fig. 3B–E). Because axons and Schwann cells are in
direct contact, we cannot rule out that some of the changes in sciatic
nerve occurred on Schwann cells, but our in vivo results closely par-
allel changes we observed on axons in vitro, albeit with a longer time
course.
Exogenous sialidase rescues NeuAc2en-mediated inhibition
of Neu3 sialidase activity and promotes neurite regeneration
To confirm the requirement for sialidase action in axon regener-
ation and to control for nonspecific effects of NeuAc2en, a rescue
experiment was performed in cultured DRGs. After inhibiting
endogenous Neu3 sialidase activity, we treated the cultures with
exogenous sialidase to convert axonal gangliosides to GM1
(NeuAc2en  sialidase). First, a control experiment demon-
strated that the effects of NeuAc2en inhibition on axon regener-
ation persist for at least 1 h after removal. Axotomy 30 min after
removing NeuAc2en (NeuAc2en control) showed that the in-
hibitory effect of NeuAc2en on Neu3 sialidase activity persisted
after its removal, as indicated by a lack of increase in the GM1/
GD1a ratio (Fig. 4A–C,G). The regenerative ability of axons 30
min after NeuAc2en removal remained low, similar to cultures in
which the inhibitor was still present (Fig. 4H, I,L). The persistent
reduction of Neu3 activity after NeuAc2en withdrawal is unex-
pected after removal of a soluble competitive inhibitor and sug-
gests longer-term effects that influence the activity of Neu3 in the
axonal membrane. In a previous study, this inhibitor caused
changes in axonalmembrane structures and the cytoskeleton that
persisted after inhibitor removal (Da Silva et al., 2005).
Having confirmed the persistent blocking of Neu3 sialidase
activity after NeuAc2en removal, we assessed whether exogenous
Clostridium sialidase dissolved in the culture medium could con-
vert GD1a to GM1. Application of sialidase increased the GM1/
GD1a ratio in uncut axons to the level found after axotomy, and
axotomy after sialidase treatment did not further increase GM1
levels (Fig. 4D–G). Treatment of Neu3 sialidase-inhibited cul-
tures with sialidase restored their regenerative ability near the
levels observed in normal conditions (Fig. 4J–L). These results
Figure 6. Axon regeneration is regulated by eCa 2, P38MAPK, ERK, andmTOR signaling cascades. A–J, Phase-contrast photomicrographs of adult DRG axons photographed immediately after
axotomy (A–E) and 1 h after axotomy (F–J ), under normal conditions (control; A, F ) and after exposure to inhibitors of ERK (U0126; B, G), removal of Ca 2 (without calcium; C, H ), inhibitors of
P38MAPK (SB203580; D, I ), and mTOR (rapamycin; E, J ). Inhibition of all these pathways attenuated the ability of axons to regenerate. Percentage regeneration of axons ( SEM) is plotted in K
(n 5). ***p 0.001 (one-way ANOVA). Scale bars, 50m.
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suggest that GD1a to GM1 ganglioside conversion mediated ei-
ther by Neu3 sialidase or by externally applied sialidase is impor-
tant for regeneration of peripheral axons.
The Neu3 sialidase-mediated transient increase in the ratio of
GM1/GD1a ganglioside is not observed in retinal axons
In light of previous results, we asked whether the failure of
regeneration of CNS axons might involve an inability to in-
crease GM1 after axotomy. For these experiments, an axotomy
was performed on axons extending from adult rat retinal ex-
plants. We have previously shown that only 5% of adult retinal
axons regenerate after in vitro axotomy compared with 70% of
adult DRG axons (Chierzi et al., 2005; Verma et al., 2005). The
axons usually retract from the cut site and form an active
retraction bulb, but fail to make a new growth cone. We found
that adult retinal axons have a lower ratio of GM1/GD1a ganglio-
sides on their surface than DRG axons. Additionally, there was no
conversion of GD1a to GM1 ganglioside 15 min after axotomy in
retinal axons (Fig. 5A,B). To determinewhether this was due to low
levels of Neu3 sialidase in retinal axons, its abundance and distribu-
tionwere assessedby immunofluorescence. Similar levels of staining
and distribution of Neu3 sialidase to that found in DRG cultures
were observed (Fig. 5E). To investigate whether the conversion of
GD1a to GM1 can occur in these axons in the presence of active
sialidase, we applied exogenous sialidase to retinal cultures. The
treatment induced high levels of GM1 ganglioside on retinal axons,
bringing the GM1/GD1a ratio close to that of axotomized or
sialidase-treated adult DRG axons (Fig. 5C,D,F). These experi-
ments suggest that Neu3 sialidase is present on adult retinal axons
but is not activated by axotomy.
Figure7. Neu3 sialidase activity is affected by eCa 2, P38MAPK, and ERK in adult DRG axons after axotomy.A–J, Fluorescent photomicrographs of adult DRG axons uncut (A–E) and 15min after
axotomy (F–J ), double-labeled for GD1a (green) and GM1 gangliosides (CTB, red) under normal conditions (control; A, F ) and after exposure to inhibitors of ERK (U0126; B, G), removal of Ca 2
(without calcium; C,H ), inhibitors of P38MAPK (SB203580;D, I ) ormTOR (rapamycin; E, J ). The ratio of GM1/GD1a ganglioside intensities ( SEM) normalized against background intensity levels
is plotted in K (40–50 axons/chamber, 2 DRGs/chamber, n 3 chambers). To avoid variability among uncut axons, axonal ratios of GM1/GD1a intensity levels were assigned the arbitrary value of
1 and GM1/GD1a levels at 15 min and 1 h after axotomy were normalized against corresponding uncut axons’ ratio. L,M, The ratio of pP38MAPK/P38MAPK (L; uncut, n 4; 15 min, n 6) and
pERK/ERK (M; uncut, n 4; 15min, n 4) uncut and 15min after injury is plotted SEM. ***p 0.001 (two-way ANOVA). **p 0.01 (Student’s t test, two-tailed). *p 0.05 (Student’s t test,
two-tailed). Scale bars: A–J, 50m.
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To determine whether conversion of gangliosides by sialidase
activity occurs after damage to the CNS in vivo, we performed an
optic nerve crush injury in adult rats and measured GM1/GD1a
levels in narrow regions adjacent to the axonal marker III-
tubulin. No change in theGM1/GD1a ratio was observed in these
axonal regions of the optic nerve after injury, and the ratio in
undamaged nerves was similar to uncrushed sciatic nerve (Fig.
5G-I,G–I,J).
Treatment of retinal axons with
sialidase increases their regeneration
after axotomy
We next examined whether exogenous
sialidase treatment enhances the ability of
adult retinal axons to regenerate. After
axotomy, retinal axons showed greater re-
traction than DRG axons, with many ax-
ons retracting out of the field of view (Fig.
5K–O). Furthermore, only 4.8% of con-
trol axons regrew 1 h after axotomy be-
yond their point of initial retraction,
whereas 21.3% of axons exposed to siali-
dase regenerated past their retraction
point (Fig. 5P). These results demonstrate
that conversion ofmore complex ganglio-
sides to GM1 mediated by sialidase is an
important component of the regenerative
response and that exogenous sialidase
treatment can enhance regeneration in
adult retinal axons in vitro, although not
to the level seen in sensory axons.
Neu3 sialidase activity is regulated by
eCa2, ERK, and P38MAPK in adult
DRG axons after axotomy
The preceding experiments indicate that
axotomy activates Neu3 sialidase in adult
DRG axons, but not in adult retinal axons,
and that Neu3 sialidase activation is nec-
essary for a successful regenerative response.
We therefore investigated the signaling
events that link axotomy to Neu3 sialidase
activation and then to axon regeneration.
Previous work has identified three signaling
pathways (ERK, P38MAPK, and mTOR)
(Agthong et al., 2009, 2012; Abe et al.,
2010) as well as a local Ca2 influx (Man-
dolesi et al., 2004; Cho and Cavalli, 2012;
Cho et al., 2013), which occurs in re-
sponse to axotomy and whose inhibition
diminishes successful DRG axon regener-
ation (Chierzi et al., 2005; Verma et al.,
2005). We confirmed that transient inhi-
bition of any of these pathways with stan-
dard inhibitors attenuated the ability of
adult DRG axons to regenerate (Fig. 6).
Next, we asked whether blocking these
signaling pathways affected the conver-
sion of GD1a to GM1 after axotomy.
Removal of eCa2, inhibition of ERK or
P38MAPK prevented the axotomy-
mediated increase in the GM1/GD1a ratio
after axotomy, whereas blocking mTOR
had no effect on the ratio (data shown in
Fig. 7 legend). These results suggest that Neu3 sialidase activation
in axotomized adult DRGs is regulated by a signaling cascade
involving eCa2, ERK, and P38MAPK.
Based on our results combined with knowledge of damage
responses in other cell types where P38MAPK has been shown to
be a stress response kinase (Coulthard et al., 2009), we hypothe-
sized that, after axonal injury, the rapid influx of Ca2 activates
P38MAPK, which in turn leads to increased Neu3 sialidase activ-
Figure8. P38MAPK activation is the intermediary step between eCa 2 influx andNeu3 sialidase activation after axonal injury,
whereas ERK activation is downstream of Neu3 sialidase activation. I, A–E, Fluorescent photomicrographs of adult DRG axons
uncut (A, C) and 15 min after axotomy (B, D), double-labeled for P38MAPK (red) and phospho P38MAPK (green) under normal
conditions (control; A, B) and after removal of eCa 2 (without Ca 2; C,D). The ratio of phospho P38MAPK/P38MAPK intensities
( SEM) normalized against background intensity levels is plotted in E (30–40 axons/chamber, 2 DRGs/chamber, n 4–6
chambers). II, Activation of P38MAPK using anisomycin increases Neu3 sialidase activity even in the absence of eCa 2. F–H,
Fluorescent photomicrographs of uncut adult DRG axons, double-labeled for GD1a (green) and GM1 gangliosides (CTB, red) and
under normal conditions (control; F ), after removal of eCa 2 (without Ca 2; G) and after exposure to anisomycin (AIS) in the
absence of eCa 2 (without Ca 2 AIS; H ). The ratio of GM1/GD1a ganglioside intensities ( SEM) normalized against back-
ground intensity levels is plotted in I (30–40 axons/chamber, 2 DRGs/chamber, n 4 chambers). III, ERK activation is down-
stream of Neu3 sialidase activation. J–L, Fluorescent photomicrographs of adult uncut DRG axons, labeled for pERK under control
conditions (J ) and after exposure to exogenous sialidase (K ). The ratio of pERK/ERK intensities ( SEM) normalized against
background intensity levels is plotted in L (30–40 axons/chamber, containing 2DRGs,n 6 chambers). ***p 0.001 (Student’s
t test, two-tailed). **p 0.01 (Student’s t test, two-tailed). Scale bars, 50m.
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ity. Based on previouswork,Neu3 sialidase-mediated ganglioside
conversion leads to increased signaling via the ERK pathway (Da
Silva et al., 2005). ERK activation acts on axonal growth mecha-
nisms likely as part of a positive feedback loop leading to further
activation of Neu3 sialidase (see Discussion and Fig. 9).
We first investigated phosphorylation of P38MAPK (pP38MAPK)
15 min after axotomy of adult DRG axons in the presence or
absence of eCa2. In the absence of eCa2, the increase in the
pP38MAPK/P38MAPK ratio after axotomy was significantly re-
duced, suggesting that P38MAPK is downstream of eCa2 entry
(Fig. 8A–E). We next assessed whether P38MAPK activation could
activate Neu3 sialidase. P38MAPK in uncut axons in the absence of
eCa2was first activated by a common P38MAPK activator, aniso-
mycin (Katoh-Sembaet al., 2009;Mei et al., 2012), before the surface
levels of GM1 andGD1aweremeasured. Anisomycin treatment led
to a mild increase in pP38MAPK/P38MAPK, and this in turn re-
sulted in a 3.5-fold increase in the ratio of GM1/GD1a. Although
anisomycin is not entirely specific to p38, coupled with the other
results, the experiment suggests that Neu3 sialidase was activated by
P38MAPK activation (Fig. 8F–I). Next, we examined whether gan-
glioside conversion can activate the ERK pathway, as demonstrated
previously in embryonic neurons (Da Silva et al., 2005). To test this,
we treated uncut adult DRG axons with exogenous sialidase to con-
vert GD1a toGM1. This conversion resulted in an increased ratio of
pERK/ERK(Fig. 8J–L).Together, these results support theproposed
signaling events shown in Figure 9.
P38MAPK is not activated in adult retinal axons
after axotomy
CNS axotomy has been shown to invoke a large calcium influx
(Mandolesi et al., 2004); therefore, we hypothesized that the
block in Neu3 sialidase activation in retinal axons might occur at
the P38MAPK activation step. We evaluated whether the ratio of
pP38MAPK/P38MAPK changes 15 min after axotomy in retinal
axons as observed in DRG axons. After axotomy, we did not
observe an increase in the ratio of either pP38MAPK/P38MAPK
or pERK/ERK levels (Fig. 10A–F). Therefore, we assessed
whether Neu3 sialidase activation consequent on P38MAPK ac-
tivation is operative in retinal axons. P38MAPK was activated
using anisomycin, and we measured the GM1/GD1a ganglioside
ratio. Anisomycin treatment led to a 100% increase in the levels
of GM1/GD1a ganglioside (Fig. 10G–I).
Overall, our experiments indicate that, in DRG axons,
Neu3 sialidase activation after axonal injury is triggered by influx
of eCa2 after membrane rupture, leading to activation of
P38MAPK. However, in retinal axons, neither P38MAPK nor
Neu3 sialidase is activated after axotomy. ActiveNeu3 sialidase or
an externally applied sialidase changes the ratio of GM1/GD1a
ganglioside, leading to ERK pathway activation and a successful
regeneration response.
Discussion
Our study demonstrates that ganglioside composition on axons is
important for growth cone production and that conversion of
axonal gangliosides to GM1 by the axonal surface enzyme Neu3
sialidase is required for adult axon regeneration. CNS axons lack
intrinsic regenerative ability, and our results strongly suggest that
the lack of Neu3 sialidase activation after axotomy is a factor in
poor regenerative ability. The importance of sialidase activity for
CNS regeneration is supported by a previous study in which siali-
dase treatment after spinal cord injury promoted axon regenera-
tion (Yang et al., 2006) and functional recovery (Mountney et al.,
2010, 2013). Further work has shown that conversion of ganglio-
sides to GM1 by Neu3 sialidase is critical during early neuronal
differentiation for axonal specification (Da Silva et al., 2005;
Abad-Rodriguez and Robotti, 2007). Furthermore, poor regen-
Figure9. Diagramofproposed signaling cascade regulatingNeu3 sialidaseactivity.Membrane ruptureafter axotomy leads to increased influxof eCa 2 into injuredaxons.Whereas in adultDRGs
this results in either direct activation of Neu3 sialidase or an increased phosphorylation of P38MAPK resulting in increased Neu3 sialidase activation, this process is absent in adult retinal axons.
Furthermore, ERK is activateddownstreamofNeu3 sialidase,which in turn further activatesNeu3 sialidase throughapositive feedback loop, a step attenuated in retinal axons, resulting in a two step
block for successful Neu3 sialidase activity mediated regeneration.
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eration of PNS axons has been observed in animals lacking com-
plex gangliosides (Kittaka et al., 2008) and after treatment with
antibodies to GM1 ganglioside (Lehmann et al., 2007; Lopez et
al., 2010).
Regulation of Neu3 sialidase activity
Sialidases, such as Neu3, act to remove terminal sialic acid
groups, converting gangliosides, such as the main CNS ganglio-
sides GD1a, GD1b, and GT1b to GM1. After axotomy of DRG
neurons, we observed a rapid increase in GM1 and a decrease in
both GD1a and GT1b, which was prevented by Neu3 sialidase
inhibition through pharmacological inhibition or siRNA knock-
down. Preventing ganglioside conversion to GM1 inhibited re-
generation in PNS axons.However, replacingNeu3 sialidase with
external sialidase after blocking it rescued regeneration by induc-
ing an increase in GM1 (and reduction in GD1a). This suggests
that PNS axotomy rapidly activates Neu3 sialidase, converting
major nervous system gangliosides to GM1. Within 1 h after
axotomy, as axons regenerated their growth cones, GD1a and
GM1 levels reverted to preaxotomy values, implying that Neu3
sialidase activation is transient. Although regulatorymechanisms
forNeu3 sialidase are unknown, the struc-
ture of Neu3 sialidase protein has been
characterized, revealing potential phos-
phorylation sites on the C terminus
(Miyagi et al., 1999). After in vitro axo-
tomy, there is a transient influx of calcium
and rapid activation of several signaling
pathways, including P38MAPK, ERK, and
PI3 kinase (Liu and Snider, 2001; Chierzi
et al., 2005; Verma et al., 2005). Our re-
sults show that blockade of these path-
ways prevents Neu3 sialidase activation
after axotomy. The first step inNeu3 siali-
dase activation is calcium influx into the
damaged axon which we found to be
necessary for GD1a to GM1 ganglioside
conversion, and for activation of other
signaling pathways. Calcium influx after
axotomy initiates several other processes
involved in regeneration, including acti-
vation of calpain and Ca2-dependent ki-
nases (Ziv and Spira, 1997; Chierzi et al.,
2005; Kamber et al., 2009). The next step
we identifiedwas activation of P38MAPK,
a stress-related kinase, activated by stressors
including calcium (Nozaki et al., 2001). Ac-
tivation of P38MAPK by anisomycin trig-
gered sialidase activity, confirming
P38MAPK as a link between axotomy and
Neu3 sialidase activation.However, we do
not know whether P38MAPK binds di-
rectly to Neu3 sialidase or whether it acts
via an intermediary step. Evidence dem-
onstrates that P38MAPK activation is es-
sential for efficient axon regeneration
(Myers et al., 2003; Verma et al., 2005; Nix
et al., 2011; Kato et al., 2013). Axotomy
also activated ERK, which is a step in the
major signaling pathway controlling axon
growth (Chierzi et al., 2005; Waetzig and
Herdegen, 2005). Neu3 sialidase activa-
tion and ganglioside conversion is suffi-
cient to activate ERK, confirmed with ERK activation in axons
treated with exogenous sialidase. These results suggest that
P38MAPK and ERK are acting in parallel within DRG neurons
downstream of the initial calcium influx arising immediately af-
ter axotomy. This is likely the result of the construction of cell
surface signaling domains (rafts), of which GM1 is a major orga-
nizer (Ichikawa et al., 2009;Ohkawa et al., 2010; Singh et al., 2010;
Furukawa et al., 2011). These domains contain various activators
of signaling pathways, such as integrins, growth factor receptors,
and other signalingmolecules. In embryonic neurons,Neu3 siali-
dase action can affect axons by increasing TrkA signaling result-
ing in ERK activation (Da Silva et al., 2005).
Neu3 sialidase activation fails in CNS axons
Although Neu3 sialidase was activated by axotomy in DRG ax-
ons, we observed no such change in adult retinal axons, despite
the presence of Neu3 sialidase protein on the axons. These results
suggest that there is a failure in the mechanisms that activate
Neu3 after axotomy. Where might activation fail? Axotomy of
CNS axons causes calcium influx as in PNS axons (Mandolesi et
al., 2004), but we did not observe activation of P38MAPK after
Figure10. P38MAPK and ERK are not activatedwithin 15min after axotomy in retinal axons, but forced activation of P38MAPK
increases Neu3 sialidase activity in retinal axons. I, A–D, Fluorescent photomicrographs of adult retinal axons uncut (A,C) and 15
min after axotomy (B,D), double-labeled for P38MAPK (A,B) or ERK (C,D) (red) and pP38MAPK (A,B) or pERK (C,D) (green). Ratios
of pP38MAPK/P38MAPK and pERK/ERK intensities ( SEM) normalized against background intensity levels are plotted in E and F
(30–40axons/chamber,n4 chambers). II,G,H, Fluorescent photomicrographs of adult uncut retinal axons, double-labeled for
GD1a (green) and GM1 gangliosides (CTB, red). Anisomycin increased the GM1/GD1a ratio (compare H with G). I, Ratios of
GM1/GD1a ganglioside intensities ( SEM) normalized against background intensity levels are plotted in I (30–40 axons/
chamber, n 7). ***p 0.001 (Student’s t test, 2-tailed). Scale bars, 50m.
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axotomy in retinal axons. Alternatively, if P38MAPK is pharma-
cologically activated, retinal axons show sialidase activity with
ganglioside conversion, suggesting a defect in the pathway lead-
ing to P38MAPK activation. Interestingly, axonal regeneration in
P38MAPK knock-out mice was shown to be substantially lower
than in wild-typemice (Kato et al., 2013). It is not clear why there
is a differential regulation of P38MAPK between the two neuro-
nal types; however, we hypothesize that the differential activity
profile of RhoA in CNS and PNS axons may partially explain this
difference. It has been shown to be activated by themyelin inhib-
itor Nogo-A (absent in PNS), which acts to suppress P38MAPK
levels in CNS neurons after (MCAO) injury (Kilic et al., 2010),
inhibiting regeneration. There is also evidence demonstrating
that the formation of a complex between GT1b and the Nogo
receptor NgR1 inhibits axon growth in cerebellar granular neu-
rons (Williams et al., 2008). Likewise, upregulation of cytokines
after injury, such as TNF-, has also been shown to activate RhoA
in cultured hippocampal neurons leading to reduced P38MAPK
activation (Neumann et al., 2002). However, TNF- has an op-
posite effect in DRG neurons leading to increases in after injury
calcium influx and activation of P38MAPK (Pollock et al., 2002).
Actions of Neu3 sialidase
Neu3 sialidase is membrane-associated, and its action is known
to be specific to membrane gangliosides (Miyagi et al., 1999).
Neu3 sialidase might affect axon regeneration in several ways. In
one well-established mechanism, GD1a is a coreceptor for the
inhibitory molecule MAG, present on PNS- and CNS-
myelinating cells (Collins et al., 1997; Vyas et al., 2002). Conver-
sion of GD1a to GM1 therefore diminishes inhibition by MAG.
Although important in vivo, where axons andmyelinating glia are
in close contact, it is not likely to be the mechanism behind the
positive effect of sialidase in our in vitro assays as these axonswere
not in contactwithmyelinating glia, and inhibition of ganglioside
synthesis blocked rather than stimulated axon regeneration. In-
stead, our results suggest a positive effect of GM1 on axon regen-
eration. However, in addition to the “growth-promoting effect”
of increased GM1 levels, it is possible that the increase in regen-
erationwas also the result of a reduction of complex gangliosides,
such as GD1a or GT1b. All interventions that increased axonal
GM1 increased regeneration and those that inhibited conversion
of polysialylated gangliosides to GM1 blocked regeneration. This
conclusion is strengthened by our results with axotomized retinal
axons, which do not upregulate GM1 ganglioside and fail to re-
generate unless treated with sialidase to convert surface ganglio-
sides to GM1. Potential mechanisms have been proposed to
explain how GM1 might enable growth cone regeneration,
mostly based on the ability of GM1 to organize lipid-rich mi-
crodomains/rafts (Furukawa et al., 2011). Disruption of one type
of raft throughmanipulation of flotillins affects regeneration, for
example (Stuermer, 2010). Additionally, extensive literature on
cancer invasion and Neu3 sialidase exists showing that Neu3
sialidase is localized to membrane ruffles in GM1-rich rafts dur-
ing metastasis (Yamaguchi et al., 2006; Miyagi et al., 2008a,b;
Miyata et al., 2011; Tringali et al., 2012). Metastatic transforma-
tion and growth cone advance share a requirement formembrane
extension, decreased adhesiveness to substrate at the leading
edge, and formation of fillipodia and lamellipodia. In tumor cells,
Neu3 sialidase has effects on adhesion, integrin turnover and
activation, caspase activity, caveolins, and several signaling path-
ways (Roche et al., 1997; Miyagi et al., 2008a,b; Tringali et al.,
2012). Disruption of microdomains/rafts might explain why
mice lacking complex gangliosides have decreased expression of
neurotrophic factors and their receptors (Kittaka et al., 2008),
and why GM1 ganglioside potentiates the activity of NGF recep-
tor, TrkA, in addition to other neurotrophin receptors (Ba¨hr et
al., 1989; Cuello et al., 1994; Rabin andMocchetti, 1995; Rabin et
al., 2002). Additionally, it is likely that Neu3 sialidase activation
may lead to its association with integrins, further leading to acti-
vation of FAK and calcium influx (Wu et al., 2007), an event
important for cytoskeletal reorganization and axonal guidance
(Kato et al., 2006; Miyagi et al., 2008b).
The experiments in this paper demonstrate that an increase in
the ratio of growth-promoting gangliosides (GM1) to growth-
inhibiting gangliosides (such as GD1a and GT1b) mediated by
Neu3 sialidase play an important role in changes that lead to axon
regeneration after axotomy.Much of the detail about cytoskeletal
changes that occur after axotomy is known (Spira et al., 2003;
Erez et al., 2007; Ertu¨rk et al., 2007), and we are beginning to
understand the process of local mRNA translation (Hanz et al.,
2003; Willis et al., 2005; Vogelaar et al., 2009; Yoo et al., 2010;
Jung et al., 2012). Equally important are changes on the cell sur-
face, and our results strongly suggest that understanding these
events will enable interventions that enhance the intrinsic regen-
erative ability of axons.
References
Abad-Rodriguez J, Robotti A (2007) Regulation of axonal development by
plasma membrane gangliosides. J Neurochem 103:47–55. CrossRef
Medline
Abe N, Borson SH, Gambello MJ, Wang F, Cavalli V (2010) Mammalian
target of rapamycin (mTOR) activation increases axonal growth capacity
of injured peripheral nerves. J Biol Chem 285:28034–28043. CrossRef
Medline
Afshari FT, Kappagantula S, Fawcett JW (2009) Extrinsic and intrinsic fac-
tors controlling axonal regeneration after spinal cord injury. Expert Rev
Mol Med 11:e37. CrossRef Medline
Agthong S, Koonam J, Kaewsema A, Chentanez V (2009) Inhibition of
MAPK ERK impairs axonal regeneration without an effect on neuronal
loss after nerve injury. Neurol Res 31:1068–1074. CrossRef Medline
Agthong S, Kaewsema A, Chentanez V (2012) Inhibition of P38 MAPK re-
duces loss of primary sensory neurons after nerve transection. Neurol Res
34:714–720. CrossRef Medline
Ba¨hr M, Vanselow J, Thanos S (1989) Ability of adult rat ganglion cells to
regrow axons in vitro can be influenced by fibroblast growth factor and
gangliosides. Neurosci Lett 96:197–201. CrossRef Medline
Bradke F, Dotti CG (1999) The role of local actin instability in axon forma-
tion. Science 283:1931–1934. CrossRef Medline
Bradke F, Fawcett JW, SpiraME (2012) Assembly of a new growth cone after
axotomy: the precursor to axon regeneration. Nat Rev Neurosci 13:183–
193. CrossRef Medline
Chew DJ, Fawcett JW, AndrewsMR (2012) The challenges of long-distance
axon regeneration in the injured CNS. Prog Brain Res 201:253–294.
CrossRef Medline
Chierzi S, Ratto GM, Verma P, Fawcett JW (2005) The ability of axons to
regenerate their growth cones depends on axonal type and age, and is
regulated by calcium, cAMP and ERK. Eur J Neurosci 21:2051–2062.
CrossRef Medline
ChoY,Cavalli V (2012) HDAC5 is a novel injury-regulated tubulin deacety-
lase controlling axon regeneration. EMBO J 31:3063–3078. CrossRef
Medline
Cho Y, Sloutsky R, Naegle KM, Cavalli V (2013) Injury-induced HDAC5
nuclear export is essential for axon regeneration. J Neurosci 155:894–908.
CrossRef
Collins BE, Yang LJ, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A,
Schnaar RL (1997) Sialic acid specificity of myelin-associated glycopro-
tein binding. J Biol Chem 272:1248–1255. CrossRef Medline
Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA (2009)
P38(MAPK): stress responses from molecular mechanisms to therapeu-
tics. Trends Mol Med 15:369–379. CrossRef Medline
Cuello AC, Garofalo L, Liberini P, Maysinger D (1994) Cooperative effects
of gangliosides on trophic factor-induced neuronal cell recovery and syn-
2490 • J. Neurosci., February 12, 2014 • 34(7):2477–2492 Kappagantula et al. • Neu3 Sialidase Is Required for Axon Regeneration
aptogenesis: studies in rodents and subhuman primates. Prog Brain Res
101:337–355. CrossRef Medline
Da Silva JS, Hasegawa T, Miyagi T, Dotti CG, Abad-Rodriguez J (2005)
Asymmetricmembrane ganglioside sialidase activity specifies axonal fate.
Nat Neurosci 8:606–615. CrossRef Medline
Erez H,Malkinson G, Prager-KhoutorskyM, De Zeeuw CI, Hoogenraad CC,
Spira ME (2007) Formation of microtubule-based traps controls the
sorting and concentration of vesicles to restricted sites of regenerating
neurons after axotomy. J Cell Biol 176:497–507. CrossRef Medline
Ertu¨rk A, Hellal F, Enes J, Bradke F (2007) Disorganized microtubules un-
derlie the formation of retraction bulbs and the failure of axonal regener-
ation. J Neurosci 27:9169–9180. CrossRef Medline
Facci L, Leon A, Toffano G, Sonnino S, Ghidoni R, Tettamanti G (1984)
Promotion of neuritogenesis inmouse neuroblastoma cells by exogenous
gangliosides: relationship between the effect and the cell association of
ganglioside GM1. J Neurochem 42:299–305. CrossRef Medline
FurukawaK,Ohmi Y,OhkawaY, TokudaN, KondoY,TajimaO, FurukawaK
(2011) Regulatory mechanisms of nervous systems with glycosphingo-
lipids. Neurochem Res 36:1578–1586. CrossRef Medline
Gao X, Lowry PR, Zhou X, Depry C, Wei Z, Wong GW, Zhang J (2011)
PI3K/Akt signaling requires spatial compartmentalization in plasma
membrane microdomains. Proc Natl Acad Sci U S A 108:14509–14514.
CrossRef Medline
Geisler FH, Coleman WP, Grieco G, Poonian D (2001) The Sygen multi-
center acute spinal cord injury study. Spine 26:S87–S98. CrossRef
Medline
Grider MH, Park D, Spencer DM, Shine HD (2009) Lipid raft-targeted Akt
promotes axonal branching and growth cone expansion via mTOR and
Rac1, respectively. J Neurosci Res 87:3033–3042. CrossRef Medline
Guirland C, Zheng JQ (2007) Membrane lipid rafts and their role in axon
guidance. Adv Exp Med Biol 621:144–155. CrossRef Medline
Guirland C, Suzuki S, KojimaM, Lu B, Zheng JQ (2004) Lipid rafts mediate
chemotropic guidance of nerve growth cones. Neuron 42:51–62.
CrossRef Medline
Hanz S, Perlson E, Willis D, Zheng JQ, Massarwa R, Huerta JJ, Koltzenburg
M, Kohler M, van-Minnen J, Twiss JL, Fainzilber M (2003) Axoplasmic
importins enable retrograde injury signaling in lesioned nerve. Neuron
40:1095–1104. CrossRef Medline
Ichikawa N, Iwabuchi K, Kurihara H, Ishii K, Kobayashi T, Sasaki T, Hattori
N, Mizuno Y, Hozumi K, Yamada Y, Arikawa-Hirasawa E (2009) Bind-
ing of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for
neurite outgrowth. J Cell Sci 122:289–299. CrossRef Medline
Jung H, Yoon BC, Holt CE (2012) Axonal mRNA localization and local
protein synthesis in nervous system assembly, maintenance and repair.
Nat Rev Neurosci 13:308–324. CrossRef Medline
Kalka D, von Reitzenstein C, Kopitz J, Cantz M (2001) The plasma mem-
brane ganglioside sialidase cofractionates with markers of lipid rafts.
Biochem Biophys Res Commun 283:989–993. CrossRef Medline
Kamber D, Erez H, Spira ME (2009) Local calcium-dependent mechanisms
determine whether a cut axonal end assembles a retarded endbulb or
competent growth cone. Exp Neurol 219:112–125. CrossRef Medline
Kamiguchi H (2006) The region-specific activities of lipid rafts during axon
growth and guidance. J Neurochem 98:330–335. CrossRef Medline
Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K, Saijo S,
Miyagi T (2006) Plasma-membrane-associated sialidase (Neu3) differ-
entially regulates integrin-mediated cell proliferation through laminin-
and fibronectin-derived signalling. Biochem J 394:647–656. CrossRef
Medline
Kato N, MatsumotoM, KogawaM, Atkins GJ, Findlay DM, Fujikawa T, Oda
H, Ogata M (2013) Critical role of P38 MAPK for regeneration of the
sciatic nerve following crush injury in vivo. J Neuroinflammation 10:1.
CrossRef Medline
Katoh-Semba R, Kaneko R, Kitajima S, Tsuzuki M, Ichisaka S, Hata Y,
Yamada H, Miyazaki N, Takahashi Y, Kato K (2009) Activation of P38
mitogen-activated protein kinase is required for in vivo brain-derived
neurotrophic factor production in the rat hippocampus. Neuroscience
163:352–361. CrossRef Medline
Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Schwab ME,
Hermann DM (2010) Role of Nogo-A in neuronal survival in the reper-
fused ischemic brain. J Cereb Blood Flow Metab 30:969–984. CrossRef
Medline
Kittaka D, Itoh M, Ohmi Y, Kondo Y, Fukumoto S, Urano T, Tajima O,
Furukawa K (2008) Impaired hypoglossal nerve regeneration inmutant
mice lacking complex gangliosides: down-regulation of neurotrophic fac-
tors and receptors as possible mechanisms. Glycobiology 18:509–516.
CrossRef Medline
Kopitz J, von Reitzenstein C, Sinz K, Cantz M (1996) Selective ganglioside
desialylation in the plasma membrane of human neuroblastoma cells.
Glycobiology 6:367–376. CrossRef Medline
Lehmann HC, Lopez PH, Zhang G, Ngyuen T, Zhang J, Kieseier BC, Mori S,
Sheikh KA (2007) Passive immunization with anti-ganglioside antibod-
ies directly inhibits axon regeneration in an animal model. J Neurosci
27:27–34. CrossRef Medline
Liu RY, Snider WD (2001) Different signaling pathways mediate regenera-
tive versus developmental sensory axon growth. J Neurosci 21:RC164.
Medline
LongKE, LemmonV (2000) Dynamic regulation of cell adhesionmolecules
during axon outgrowth. J Neurobiol 44:230–245. CrossRef Medline
Lopez PH, Zhang G, Zhang J, Lehmann HC, Griffin JW, Schnaar RL, Sheikh
KA (2010) Passive transfer of IgG anti-GM1 antibodies impairs periph-
eral nerve repair. J Neurosci 30:9533–9541. CrossRef Medline
Mandolesi G, Madeddu F, Bozzi Y, Maffei L, Ratto GM (2004) Acute phys-
iological response of mammalian central neurons to axotomy: ionic reg-
ulation and electrical activity. FASEB J 18:1934–1936. CrossRef Medline
Mei S, Gu H, Ward A, Yang X, Guo H, He K, Liu Z, Cao W (2012) P38
mitogen-activated kinase (MAPK) promotes cholesterol ester formation
accumulation in macrophages through inhibition of macroautophagy.
J Biol Chem 15:11761–11768. CrossRef Medline
Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, Sawada
M (1999) Molecular cloning and characterization of a plasma
membrane-associated sialidase specific for gangliosides. J Biol Chem 274:
5004–5011. CrossRef Medline
Miyagi T, Wada T, Yamaguchi K (2008a) Roles of plasma membrane-
associated sialidase Neu3 in human cancers. Biochim Biophys Acta 1780:
532–537. CrossRef Medline
Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K (2008b) Plasma
membrane-associated sialidase as a crucial regulator of transmembrane
signalling. J Biochem 144:279–285. CrossRef Medline
Miyata M, Kambe M, Tajima O, Moriya S, Sawaki H, Hotta H, Kondo Y,
Narimatsu H, Miyagi T, Furukawa K, Furukawa K (2011) Membrane
sialidase Neu3 is highly expressed in human melanoma cells promoting
cell growth with minimal changes in the composition of gangliosides.
Cancer Sci 102:2139–2149. CrossRef Medline
Monti E, Miyagi T (2012) Structure and function of mammalian sialidases.
Top Curr Chem. Advance online publication. Retrieved May 26, 2012.
doi: 10.1007/128_2012_328. CrossRef Medline
Moore DL, Goldberg JL (2011) Multiple transcription factor families regu-
late axon growth and regeneration. Dev Neurobiol 71:1186–1211.
CrossRef Medline
Mountney A, Zahner MR, Lorenzini I, Oudega M, Schramm LP, Schnaar RL
(2010) Sialidase enhances recovery from spinal cord contusion injury.
Proc Natl Acad Sci U S A 107:11561–11566. CrossRef Medline
Mountney A, Zahner MR, Sturgill ER, Riley CJ, Aston JW, Oudega M, Sch-
ramm LP, Hurtado A, Schnaar RL (2013) Sialidase, chondroitinase
ABC, and combination therapy after spinal cord contusion injury. J Neu-
rotrauma 30:181–190. CrossRef Medline
Myers RR, Sekiguchi Y, Kikuchi S, Scott B,Medicherla S, Protter A, Campana
WM (2003) Inhibition of P38 MAP kinase activity enhances axonal re-
generation. Exp Neurol 184:606–614. CrossRef Medline
NeumannH, Schweigreiter R, Yamashita T, Rosenkranz K,Wekerle H, Barde
YA (2002) Tumor necrosis factor inhibits neurite outgrowth and
branching of hippocampal neurons by a -dependent mechanism. J Neu-
rosci 22:854–862. Medline
Nix P, Hisamoto N, Matsumoto K, Bastiani M (2011) Axon regeneration
requires coordinate activation of P38 and JNK MAPK pathways. Proc
Natl Acad Sci U S A 108:10738–10743. CrossRef Medline
Norambuena A, Schwartz MA (2011) Effects of integrin-mediated cell ad-
hesion on plasma membrane lipid raft components and signaling. Mol
Biol Cell 22:3456–3464. CrossRef Medline
Nozaki K, Nishimura M, Hashimoto N (2001) Mitogen-activated protein
kinases and cerebral ischemia.Mol Neurobiol 23:1–19. CrossRefMedline
Oehler C, Kopitz J, CantzM (2002) Substrate specificity and inhibitor stud-
ies of a membrane-bound ganglioside sialidase isolated from human
brain tissue. Biol Chem 383:1735–1742. CrossRef Medline
Kappagantula et al. • Neu3 Sialidase Is Required for Axon Regeneration J. Neurosci., February 12, 2014 • 34(7):2477–2492 • 2491
Ohkawa Y,Miyazaki S, Hamamura K, KambeM,MiyataM, Tajima O, Ohmi
Y, Yamauchi Y, Furukawa K, Furukawa K (2010) Ganglioside GD3 en-
hances adhesion signals and augmentsmalignant properties ofmelanoma
cells by recruiting integrins to glycolipid-enriched microdomains. J Biol
Chem 285:27213–27223. CrossRef Medline
Okada M, Itoh Mi M, Haraguchi M, Okajima T, Inoue M, Oishi H, Matsuda
Y, Iwamoto T, Kawano T, Fukumoto S, Miyazaki H, Furukawa K, Aizawa
S, Furukawa K (2002) b-Series ganglioside deficiency exhibits no defi-
nite changes in the neurogenesis and the sensitivity to Fas-mediated apo-
ptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol
Chem 277:1633–1636. CrossRef Medline
Pollock J, McFarlane SM, Connell MC, Zehavi U, Vandenabeele P, MacEwan
DJ, Scott RH (2002) TNF-alpha receptors simultaneously activate Ca2
mobilisation and stress kinases in cultured sensory neurones. Neurophar-
macology 42:93–106. CrossRef Medline
Rabin SJ, Mocchetti I (1995) GM1 ganglioside activates the high-affinity
nerve growth factor receptor trkA. J Neurochem 65:347–354. CrossRef
Medline
Rabin SJ, Bachis A, Mocchetti I (2002) Gangliosides activate Trk receptors
by inducing the release of neurotrophins. J Biol Chem 277:49466–49472.
CrossRef Medline
Roche PH, Figarella-Branger D, Daniel L, Bianco N, Pellet W, Pellissier JF
(1997) Expression of cell adhesion molecules in normal nerves, chronic
axonal neuropathies and Schwann cell tumors. J Neurol Sci 151:127–133.
CrossRef Medline
Rodriguez JA, Piddini E, Hasegawa T, Miyagi T, Dotti CG (2001) Plasma
membrane ganglioside sialidase regulates axonal growth and regeneration
in hippocampal neurons in culture. J Neurosci 21:8387–8395. Medline
Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW,
Schnaar RL (1999) Mice lacking complex gangliosides develop Walle-
rian degeneration and myelination defects. Proc Natl Acad Sci U S A
96:7532–7537. CrossRef Medline
Singh RD, Marks DL, Holicky EL, Wheatley CL, Kaptzan T, Sato SB, Ko-
bayashi T, Ling K, Pagano RE (2010) Gangliosides and beta1-integrin
are required for caveolae and membrane domains. Traffic 11:348–360.
CrossRef Medline
Skaper SD, Katoh-Semba R, Varon S (1985) GM1 ganglioside accelerates
neurite outgrowth from primary peripheral and central neurons under
selected culture conditions. Brain Res 355:19–26. Medline
Spira ME, Oren R, Dormann A, Gitler D (2003) Critical calpain-dependent
ultrastructural alterations underlie the transformation of an axonal seg-
ment into a growth cone after axotomy of cultured Aplysia neurons.
J Comp Neurol 457:293–312. CrossRef Medline
Stuermer CA (2010) The reggie/flotillin connection to growth. Trends Cell
Biol 20:6–13. CrossRef Medline
Sun F, He Z (2010) Neuronal intrinsic barriers for axon regeneration in the
adult CNS. Curr Opin Neurobiol 20:510–518. CrossRef Medline
Tringali C, Lupo B, Silvestri I, Papini N, Anastasia L, Tettamanti G, Vene-
rando B (2012) The plasma membrane sialidase Neu3 regulates the
malignancy of renal carcinoma cells by controlling 1 integrin inter-
nalization and recycling. J Biol Chem 287:42835–42845. CrossRef
Medline
Verma P, Chierzi S, Codd AM, Campbell DS,Meyer RL, Holt CE, Fawcett JW
(2005) Axonal protein synthesis and degradation are necessary for effi-
cient growth cone regeneration. J Neurosci 25:331–342. CrossRef
Medline
Vogelaar CF, Gervasi NM, Gumy LF, Story DJ, Raha-Chowdhury R, Leung
KM, Holt CE, Fawcett JW (2009) Axonal mRNAs: characterisation and
role in the growth and regeneration of dorsal root ganglion axons and
growth cones. Mol Cell Neurosci 42:102–115. CrossRef Medline
VyasAA, PatelHV, Fromholt SE,Heffer-LaucM,VyasKA,Dang J, Schachner
M, Schnaar RL (2002) Gangliosides are functional nerve cell ligands for
myelin-associated glycoprotein (MAG), an inhibitor of nerve regenera-
tion. Proc Natl Acad Sci U S A 99:8412–8417. CrossRef Medline
Waetzig V, Herdegen T (2005) MEKK1 controls neurite regrowth after ex-
perimental injury by balancing ERK1/2 and JNK2 signaling. Mol Cell
Neurosci 30:67–78. CrossRef Medline
Wang Z, Jin Y (2011) Genetic dissection of axon regeneration. Curr Opin
Neurobiol 21:189–196. CrossRef Medline
Williams G, Wood A, Williams EJ, Gao Y, Mercado ML, Katz A, Joseph-
McCarthy D, Bates B, Ling HP, Aulabaugh A, Zaccardi J, Xie Y, Pangalos
MN,Walsh FS, Doherty P (2008) Ganglioside inhibition of neurite out-
growth requiresNogo receptor function: identification of interaction sites
and development of novel antagonists. J Biol Chem 283:16641–16652.
CrossRef Medline
Willis D, Li KW, Zheng JQ, Chang JH, Smit AB, Kelly T, Merianda TT,
Sylvester J, van Minnen J, Twiss JL (2005) Differential transport and
local translation of cytoskeletal, injury-response, and neurodegeneration
protein mRNAs in axons. J Neurosci 25:778–791. CrossRef Medline
WitteH,NeukirchenD, Bradke F (2008) Microtubule stabilization specifies
initial neuronal polarization. J Cell Biol 180:619–632. CrossRef Medline
Wu G, Lu ZH, Obukhov AG, Nowycky MC, Ledeen RW (2007) Induction
of calcium influx through TRPC5 channels by cross-linking of GM1 gan-
glioside associated with alpha5beta1 integrin initiates neurite outgrowth.
J Neurosci 27:7447–7458. CrossRef Medline
Yamaguchi K, Hata K, Wada T, Moriya S, Miyagi T (2006) Epidermal
growth factor-induced mobilization of a ganglioside-specific sialidase
(Neu3) to membrane ruffles. Biochem Biophys Res Commun 346:484–
490. CrossRef Medline
Yang LJ, Lorenzini I, Vajn K, Mountney A, Schramm LP, Schnaar RL (2006)
Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci
U S A 103:11057–11062. CrossRef Medline
Yoo S, van Niekerk EA, Merianda TT, Twiss JL (2010) Dynamics of axonal
mRNA transport and implications for peripheral nerve regeneration. Exp
Neurol 223:19–27. CrossRef Medline
ZhangG, LehmannHC,Manoharan S,HashmiM, Shim S,MingGL, Schnaar
RL, Lopez PH, Bogdanova N, Sheikh KA (2011) Anti-ganglioside
antibody-mediated activation of RhoA induces inhibition of neurite out-
growth. J Neurosci 31:1664–1675. CrossRef Medline
Zheng JQ, Kelly TK, Chang B, Ryazantsev S, Rajasekaran AK, Martin KC,
Twiss JL (2001) A functional role for intra-axonal protein synthesis dur-
ing axonal regeneration from adult sensory neurons. J Neurosci 21:9291–
9303. Medline
Ziv NE, Spira ME (1997) Localized and transient elevations of intracellular
Ca2 induce the dedifferentiation of axonal segments into growth cones.
J Neurosci 17:3568–3579. Medline
2492 • J. Neurosci., February 12, 2014 • 34(7):2477–2492 Kappagantula et al. • Neu3 Sialidase Is Required for Axon Regeneration
